Opportunity Information: Apply for RFA RM 10 003

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Large Scale Production of Perturbagen Induced Cellular Signatures (U54)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310 Trans NIH Research Support.
  • This funding opportunity was created on Feb 26, 2010 and posted on Feb 26, 2010.
  • Applicants must submit their applications by Apr 27, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $12,700,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $900,000.00 in funding.
  • Eligible applicants include: Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) County governments Special district governments City or township governments Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) Independent school districts Public and State controlled institutions of higher education For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for RFA RM 10 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Institutes of Health (NIH) funding opportunity titled "Large Scale Production of Perturbagen Induced Cellular Signatures (U54)" (Funding Opportunity Number RFA-RM-10-003) was created to launch a pilot-scale, high-throughput data production effort under the Library of Integrated Network-based Cellular Signatures (LINCS) program. The central idea is to generate and organize large, standardized datasets that capture how cells respond when they are intentionally perturbed by different agents, then use those response patterns to draw mechanism-based connections across genes, pathways, drugs, and disease-relevant biology. In practical terms, the program aims to turn many individual perturbation experiments into a coherent, searchable knowledge base of cellular "signatures" that the broader research community can use for years.

The scientific focus is on systematically collecting informative molecular activity and cellular feature readouts after applying a wide range of perturbing agents to carefully selected cell types. The FOA explicitly highlights perturbagens such as siRNAs (used to reduce or silence gene expression) and small bioactive molecules (including compounds that can mimic, inhibit, or otherwise modulate biological targets). By applying these perturbations in a controlled and scalable way across selected cell models, awardees would generate response signatures that can be compared across conditions to reveal functional relationships. The long-term payoff NIH is aiming for is the ability to connect seemingly unrelated perturbations through shared downstream effects, which can illuminate pathways and networks that govern cellular behavior.

A major motivation behind LINCS in this FOA is enabling mechanism-based inference at scale. If two different perturbations produce highly similar cellular signatures, that similarity can suggest shared mechanisms of action, convergent pathway impacts, or related functional networks. This kind of resource can be used to support several important downstream applications: linking disease states to specific molecular or cellular phenotypes; associating diseases with gene networks rather than single genes; and clarifying or predicting the mechanisms of action for known drugs (and potentially helping to reposition drugs by matching drug-induced signatures to disease-associated signatures). The program is framed as building a "long lived resource," meaning the datasets are intended to persist beyond the award period and be broadly reusable by the community.

This particular FOA is focused on pilot-scale production rather than a full mature production program. The expectation is that funded centers will deliver a usable initial resource while simultaneously tackling the practical challenges that determine whether LINCS can scale and remain reliable. The FOA calls out three core issues that pilot awardees are expected to address: optimization of methods (so assays and workflows are robust and reproducible), integration of data (so outputs from different platforms, perturbations, and cell contexts can be combined and compared), and scalability (so the approach can grow to much larger volumes of perturbations and signatures without breaking in quality, cost, or throughput). In other words, NIH is not just paying for data generation; it is paying for production-grade processes that can become a foundation for a much larger ecosystem.

The awards are structured as U54 Specialized Centers Cooperative Agreements. That mechanism matters because it signals substantial NIH program involvement and coordination, rather than a hands-off grant. Cooperative agreements are commonly used when NIH expects awardees to work closely with program staff and with other funded components, aligning on standards, timelines, deliverables, and data-sharing expectations. The FOA also makes clear that these pilot production efforts are meant to interact with additional LINCS components that were planned for future funding rounds, including efforts aimed at developing and integrating new production-ready technologies and building informatics and data analysis tools. The pilot centers funded here are essentially positioned as the early production backbone that will need to connect smoothly to later technology and analytics investments.

In terms of funding scale and timing, NIH anticipated making up to two awards in fiscal year (FY) 2010. Applicants could request up to three years of support. The FOA states that total program funds were expected to be about $2.7 million in FY 2010, ramping up to $5 million in each of FY 2011 and FY 2012, reflecting an intent to grow the effort over time as methods stabilize and throughput increases. The listing also provides an award ceiling of $900,000 (as recorded in the opportunity metadata) and an overall estimated total funding amount of $12.7 million across the program. There was no cost sharing or matching requirement.

Eligibility is broad and includes many kinds of U.S. organizations and governments as well as certain non-U.S. entities. Eligible applicants listed include public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3) nonprofits), for-profit organizations (with small businesses explicitly included and other for-profits also eligible), and various levels of government such as state, county, city or township governments, special district governments, and independent school districts. The eligibility language also extends to Tribal governments and organizations, Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions, regional organizations, and even non-domestic (foreign) entities, indicating NIH was open to assembling the strongest possible production capabilities and collaborations.

Administratively, the opportunity falls under NIH, is categorized as a discretionary program, and uses the cooperative agreement funding instrument under a health-related activity category (CFDA 93.310). The announcement was posted on February 26, 2010, with an original and current closing date of April 27, 2010, and it was archived on May 28, 2010. The NIH Office of Extramural Research (OER) webmaster contact was provided for access or linking issues, along with a link to the full announcement on the NIH grants site.

Overall, this FOA is best understood as NIH funding for a small number of coordinated, production-oriented centers to generate the first large wave of standardized cellular response signatures to genetic and chemical perturbations, while proving that the workflows, data standards, and integration approaches can scale. The deliverable is not just datasets in isolation, but an initial, community-useful resource designed to support network-level biology, drug mechanism discovery, and future computational analyses that connect perturbations, pathways, and disease states through shared cellular signatures.

Frequently Asked Questions (FAQs)

What is the name of this NIH funding opportunity?

The funding opportunity is titled "Large Scale Production of Perturbagen Induced Cellular Signatures (U54)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is RFA-RM-10-003.

What NIH program is this opportunity associated with?

This opportunity was created as part of the Library of Integrated Network-based Cellular Signatures (LINCS) program.

What is the main goal of this FOA?

The goal is to launch a pilot-scale, high-throughput data production effort to generate and organize large, standardized datasets that capture how cells respond to intentional perturbations. These standardized cellular response patterns (or "signatures") are intended to become a coherent, searchable resource the research community can use for years.

What is meant by "perturbagen-induced cellular signatures" in this FOA?

In this FOA, "signatures" refer to informative molecular activity and cellular feature readouts collected after applying perturbing agents to selected cell types. The idea is to measure how cells change in response to each perturbation and encode those responses in standardized datasets that can be compared across many conditions.

What types of perturbing agents (perturbagens) are highlighted?

The FOA explicitly highlights perturbagens such as siRNAs (used to reduce or silence gene expression) and small bioactive molecules, including compounds that can mimic, inhibit, or otherwise modulate biological targets.

What kinds of cell models are expected to be used?

The FOA describes applying a wide range of perturbing agents to carefully selected cell types. It emphasizes controlled and scalable application across selected cell models, but does not list specific cell lines or tissues in the summary provided.

What is NIH hoping researchers can do with these cellular signatures?

NIH aims for the resulting resource to enable mechanism-based inference at scale. For example, if two different perturbations produce highly similar signatures, that similarity may suggest shared mechanisms of action, convergent pathway impacts, or related functional networks.

How could this LINCS resource be used downstream?

The FOA describes several downstream applications, including linking disease states to specific molecular or cellular phenotypes, associating diseases with gene networks rather than single genes, and clarifying or predicting mechanisms of action for known drugs. It also notes the potential for drug repositioning by matching drug-induced signatures to disease-associated signatures.

Is this FOA focused on full-scale production or a pilot phase?

This FOA is focused on pilot-scale production rather than a fully mature production program. The expectation is to deliver a usable initial resource while addressing the practical challenges required to scale reliably.

What key challenges are pilot awardees expected to address?

The FOA calls out three core issues: optimization of methods (robust, reproducible assays and workflows), integration of data (combining outputs across platforms, perturbations, and cellular contexts), and scalability (increasing volume without losing quality, cost control, or throughput).

What is the grant mechanism used for this opportunity?

The awards are U54 Specialized Centers Cooperative Agreements.

What does it mean that this is a "cooperative agreement" (U54)?

A cooperative agreement indicates substantial NIH program involvement and coordination. The FOA signals that awardees are expected to work closely with NIH program staff and coordinate with other funded components on standards, timelines, deliverables, and data-sharing expectations.

How many awards did NIH anticipate making, and when?

NIH anticipated making up to two awards in fiscal year (FY) 2010.

How long could applicants request support for?

Applicants could request up to three years of support.

What funding levels are described in the FOA summary?

The FOA states total program funds were expected to be about $2.7 million in FY 2010, ramping up to $5 million in each of FY 2011 and FY 2012. The opportunity metadata also lists an award ceiling of $900,000 and an overall estimated total funding amount of $12.7 million across the program.

Is cost sharing or matching required?

No. The FOA states there was no cost sharing or matching requirement.

Who is eligible to apply?

Eligibility is broad. The FOA lists many categories including public and private institutions of higher education; nonprofit organizations (including 501(c)(3) and non-501(c)(3) nonprofits); for-profit organizations (with small businesses explicitly included and other for-profits also eligible); and multiple levels of government (state, county, city/township, special district governments, and independent school districts).

Are Tribal entities and Minority Serving Institutions included in eligibility?

Yes. The eligibility language includes Tribal governments and organizations and specifically mentions Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).

Are U.S. territories or regional organizations eligible?

Yes. The eligibility list includes U.S. territories or possessions and regional organizations.

Are non-U.S. (foreign) organizations eligible?

Yes. The eligibility language extends to non-domestic (foreign) entities.

What federal agency is offering this opportunity?

The opportunity is offered by the National Institutes of Health (NIH).

How is this opportunity categorized administratively?

It falls under NIH, is categorized as a discretionary program, and uses the cooperative agreement funding instrument. The activity category is health-related, and the CFDA number listed is 93.310.

When was the announcement posted and when did it close?

The announcement was posted on February 26, 2010. The original and current closing date was April 27, 2010.

Is this opportunity still active?

No. The opportunity was archived on May 28, 2010.

What is meant by a "long lived resource" in this FOA?

The FOA describes the datasets as intended to persist beyond the award period and remain broadly reusable by the research community.

How does this FOA relate to other LINCS components?

The FOA indicates the pilot production centers were expected to interact with additional LINCS components planned for future funding rounds, including efforts to develop and integrate new production-ready technologies and to build informatics and data analysis tools.

What kind of deliverable is NIH looking for?

The deliverable is not just isolated datasets. NIH is seeking an initial community-useful, standardized, searchable resource of cellular response signatures, along with production-grade processes (robust methods, integrated data practices, and scalable workflows) that can serve as a foundation for expansion.

Where could applicants find the full announcement or get help with access/linking issues?

The summary notes that a link to the full announcement was available on the NIH grants site, and that an NIH Office of Extramural Research (OER) webmaster contact was provided for access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: ARRA Equipment to Enhance Training for Health Professionals Training in Primary Care Medicine and Dentistry Predoctoral Training

Previous opportunity: ARRA Equipment to Enhance Training for Health Professionals Training in Primary Care Medicine and Dentistry Physician Faculty Development

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA RM 10 003

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA RM 10 003) also looked into and applied for these:

Funding Opportunity
DEPARTMENT OF DEFENSE HIV/AIDS PREVENTION PROGRAM Apply for DHAPPBAA10 001

Funding Number: DHAPPBAA10 001
Agency: Naval Supply Systems Command
Category: Health
Funding Amount: Case Dependent
APHIAplus PROGRAM DESCRIPTION Apply for RFA 623 10 000009

Funding Number: RFA 623 10 000009
Agency: Kenya USAID Nairobi
Category: Health
Funding Amount: $76,000,000
MCH Research Network on Pregnancy Related Care Apply for HRSA 10 088

Funding Number: HRSA 10 088
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season (U18) Apply for RFA IP 10 007

Funding Number: RFA IP 10 007
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Maintaining Collection of National Violent Death Reporting System (NVDRS) Data, NCIPC Apply for CE08 80203CONT10

Funding Number: CE08 80203CONT10
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Maintaining Collection of National Violent Death Reporting System (NVDRS) Data, NCIPC Apply for CE07 70404CONT10

Funding Number: CE07 70404CONT10
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Development of the National Violent Death Reporting System (NVDRS), NCIPC Apply for CE09 90402CONT10

Funding Number: CE09 90402CONT10
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Promoting Extensive Implementation of Quality Prevention of Mother to Child Transmission (PMTCT) Activities in the Republic of Uganda Apply for CDC RFA PS04 230

Funding Number: CDC RFA PS04 230
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Strengthening Public Health Capacity and Strategic Information Systems through Cooperation with the Joint United Nations Programme on HIV/AIDS (UNAIDS) under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10157

Funding Number: CDC RFA PS10 10157
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
Providing Capacity Building Assistance to Governmental and Indigenous Organizations in order to Improve the Delivery of HIV/AIDS Services in the Democratic Republic of Congo Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10101

Funding Number: CDC RFA PS10 10101
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Family Centered Substance Abuse Treatment Grants for Adolescents and their Families Apply for TI 10 002

Funding Number: TI 10 002
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $300,000
Improving availability of safe blood transfusion services through a mentoring technical assistance (TA) relationship with The Nigerian National Blood Transfusion Service, to ensure a sustainable quality management system in the Federal Republic of Ni Apply for CDC RFA PS10 1039

Funding Number: CDC RFA PS10 1039
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $500,000
Strengthening the Capacity of the Republican AIDS Center to implement HIV Programs in the Kyrgyz Republic under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10163

Funding Number: CDC RFA PS10 10163
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Republic of Kazakhstan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10164

Funding Number: CDC RFA PS10 10164
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
New Approaches to Arrhythmia Detection and Treatment (SBIR R43/R44) Apply for PA 10 117

Funding Number: PA 10 117
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
New Approaches to Arrhythmia Detection and Treatment (STTR R41/R42) Apply for PA 10 118

Funding Number: PA 10 118
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Supporting the Republican Blood Center in the Implementation of Blood Safety Activities in the Republic of Tajikistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10169

Funding Number: CDC RFA PS10 10169
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Republic of Tajikistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10165

Funding Number: CDC RFA PS10 10165
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
Strengthening the Capacity of the Republican AIDS Center to Implement HIV Programs in the Republic of Uzbekistan under the President s Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA PS10 10166

Funding Number: CDC RFA PS10 10166
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $2,000,000
Supporting the Republican Blood Center in the Implementation of Blood Safety Activities in the Kyrgyz Republic under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10167

Funding Number: CDC RFA PS10 10167
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 10 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.